About Grail

GRAIL to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

About GRAIL

GRAIL is a healthcare company whose mission is to detect cancer early when it can be cured.

GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing (NGS) to detect cancer-related signals in the blood.

Upcoming News

GRAIL will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, at 15:20 ET.

At the conference, GRAIL will showcase its latest innovations in early cancer detection.

Why This News Matters

GRAIL's presentation at the Morgan Stanley conference is significant for several reasons.

• It provides an opportunity for GRAIL to share its latest research and developments in early cancer detection.
• It raises awareness of GRAIL's mission to eradicate cancer.
• It helps GRAIL to attract potential investors and partners.

Additional Resources

For more information on GRAIL, please visit the company's website: https://www.grail.com/

To learn more about the Morgan Stanley 22nd Annual Global Healthcare Conference, please visit the conference website: https://www.morganstanley.com/about-us/events/healthcare-conference-2024